Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives-Reference-Cited by-同舟云学术

Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives

Published:2021-01 Issue: Volume:264 Page:118712
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Naik Santoshi,Shreya Ajjappla Basavaraj,Raychaudhuri Ruchira,Pandey Abhijeet,Lewis Shaila A.,Hazarika Manali,Bhandary Sulatha V.,Rao Bola Sadashiva Satish,Mutalik Srinivas

Funder

DST

CSIR

SERB

Manipal Academy of Higher Education, Manipal

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference214 articles.

1. Delivery systems and local administration routes for therapeutic siRNA;de Carvalho Vicentini;Pharm. Res.,2013

2. Progress on ocular siRNA gene silencing therapy and drug delivery systems;Jiang;Fundam. Clin. Pharmacol.,2020

3. Gene therapy targeting glaucoma: where are we?;Liu;Surv. Ophthalmol.,2009

4. Small-interfering RNA s (siRNA s) as a promising tool for ocular therapy;Guzman-Aranguez;Br. J. Pharmacol.,2013

5. Highly efficient and safe delivery of VEGF siRNA by bioreducible fluorinated peptide dendrimers for cancer therapy;Cai;ACS Appl. Mater. Interfaces,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking ocular therapy: Harnessing the power of non-coding RNAs;Journal of Drug Delivery Science and Technology;2024-09

2. Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes;Molecular Therapy - Nucleic Acids;2024-09

3. Current developments of gene therapy in human diseases;MedComm;2024-08-16

4. Self-complementary AAV vector therapy for treating corneal cloudiness of mucopolysaccharidosis type VII (MPS VII);The Ocular Surface;2024-04

5. The current perspective and opportunities of small nucleic acid‐based therapeutics;Drug Development Research;2024-02-27